10x Genomics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to 10x Genomics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021

10x Genomics (TXG) Misses Q4 EPS by $3.64, Revenues Beat; Offers FY21 Revenue Mid-Point Guidance Below Consensus

February 17, 2021 5:05 PM EST

10x Genomics (NASDAQ: TXG) reported Q4 EPS of ($3.87), $3.64 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $100.4 million.

Recent Highlights

Revenue was $298.8 million for the full year and $112.2 million for the fourth quarter of 2020,... More